Page last updated: 2024-10-28

ibuprofen and Supranuclear Palsy, Progressive

ibuprofen has been researched along with Supranuclear Palsy, Progressive in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marras, C1
Cunningham, CR1
Hou, J1
Proudfoot, J1
Standaert, DG1
Juncos, J1
Riley, D1
Reich, SG1
Hall, D1
Kluger, B1
Bordelon, Y1
Shprecher, DR1
Litvan, I1

Other Studies

1 other study available for ibuprofen and Supranuclear Palsy, Progressive

ArticleYear
Anti-inflammatory drug use and progressive supranuclear palsy.
    Parkinsonism & related disorders, 2018, Volume: 48

    Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Female; Humans; Ib

2018